BMLLNSEBIO MEDICA LABORATORIES LMinimalNeutral
Announced Mon, 26 Oct, 2026 · 15:14 IST

Quarterly corporate governance report not applicable to SME-listed company

BMLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.7%Reaction day
₹150.00
prior close
₹146.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.1% vs market

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
+0.0
15m
+0.0
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-2.7+0.4-3.1
Next day
+3.3pendingpending
2d
———
3d
———
4d
———
5d
———
1w
———
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bio Medica Laboratories said its corporate governance report for the quarter ended 30 September 2026 is not required because its shares are listed on the NSE SME platform. It cited SEBI exemption rules for such entities and stated that applicable compliance must be completed within six months.

Likely market impact

This is an administrative disclosure exemption. No change to the company's financials, operations, or shareholder returns is announced.